Isodiol International is out in front in the race to bring CBD-derived pharmaceutical and health and wellness products to market. The company sells a wide variety of more than 30 products in the U.S., UK, China and soon Canada. Capital Ideas Media publisher Mark Bunting sits down with Isodiol Canada President Soheil Samimi, who explains the potential of the fledgling CBD market, and the company’s plans to grow organically and through acquisitions.
